Why the study?
The associations of oral contraceptive use with cardiovascular disease and all-cause death remain unclear.
Does oral contraceptive use reduce incident cardiovascular disease events and all-cause death in women without baseline cardiovascular disease?
Does oral contraceptive use reduce incident cardiovascular disease events and all-cause death in women without baseline cardiovascular disease?
Oral contraceptive use in women without baseline cardiovascular disease is associated with a lower risk of incident CVD events and all-cause death, with greater benefit observed with longer durations of use.
No takes yet. Share an insight, caveat, or question.
OC use associated with modestly lower CVD and mortality risks in women without baseline disease; leaves open confounding versus causality, warranting prospective confirmation.
Dou et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: